Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.32 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5453501 | 0.88 | BRD4 (0.33) | BRD4CREBBPDPP4DPP8DPP7 | |
| SCHEMBL19730067 | 0.77 | KMT2A (0.39) | CA1CA2CA4KMT2A | |
| SCHEMBL1937119 | 0.77 | — | — | |
| SCHEMBL24535856 | 0.77 | — | — | |
| SCHEMBL23477820 | 0.74 | POLB (0.49) | CYP2C9CYP2C19 | |
| SCHEMBL83355 | 0.74 | TSHR (0.42) | CA1CA2CA4KMT2ACYP2C9 | |
| SCHEMBL83973 | 0.74 | TSHR (0.42) | CA1CA2CA4KMT2ACYP2C9 | |
| SCHEMBL83972 | 0.74 | TSHR (0.42) | CA1CA2CA4KMT2ACYP2C9 | |
| SCHEMBL83354 | 0.74 | TSHR (0.42) | CA1CA2CA4KMT2ACYP2C9 | |
| SCHEMBL83353 | 0.74 | TSHR (0.42) | CA1CA2CA4KMT2ACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3427737-A1 | SANGLIFEHRIN DERIVATIVES AND METHODS FOR THEIR PRODUCTION | NeuroVive Pharmaceutical AB (SE) | 2019-01-16 | — | — | EP | disclosed |